查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2096467

家用透析系統市場－2026-2032年全球市場預測

Home Dialysis Systems Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，家用透析系統市場將成長至 562.8 億美元，複合年成長率為 10.91%。

主要市場統計數據
基準年 2025 272.5億美元
預計年份：2026年 302億美元
預測年份 2032 562.8億美元
複合年成長率 (%) 10.91%

居家透析系統執行摘要

隨著醫療系統應對慢性腎臟病負擔日益加重、終末期腎臟病率不斷上升、人口老化以及以患者為中心的照護需求，居家透析系統正成為腎臟替代療法的重要支柱。居家血液透析和腹膜透析使合格的患者能夠在傳統透析中心之外接受治療，這得益於小型透析機、自動化腹膜週期計、遠端監測工具、一次性耗材、水處理組件、血管通路管理以及基於遠端醫療的臨床指導。臨床證據和實踐指南支持向居家腎臟護理的過渡，這些證據表明，經過適當篩選和培訓的患者可以在家中獲得安全有效的治療，同時確保治療的柔軟性，減少就醫次數，並提高治療自主性。對於醫療服務提供者和保險公司而言，居家透析系統符合其優先事項，例如分散醫療服務、管理透析容量、降低感染風險以及長期管理慢性疾病。此領域受到許多監管要求的影響，包括醫療設備安全、透析水質、生物相容性材料、人體工學、網路安全、訓練方案、報銷機制設計以及看護者支援等。隨著腎臟護理從以診所為中心的治療模式向網路化、個人化和以結果為導向的模式發展，家庭透析系統在醫療設備創新、數位醫療、腎臟病服務和價值醫療的交匯點上佔據著日益重要的地位。

居家透析領域的變革性變化

家用透析系統正在經歷一場變革，其促進因素包括設備小型化設計、遠端患者監護、遠端腎臟病學、簡化的使用者介面以及政策對居家照護日益重視。傳統上，透析服務嚴重依賴醫療機構的基礎設施、固定的治療時間表和頻繁的患者轉運。如今，便捷易用的週期計、連網的血液透析平台、自動警報系統、雲端治療數據以及改進的培訓模式，都促進了合格的患者群體更廣泛地接受家用透析。在臨床實踐中，腎臟科醫生、護士、患者和看護者正轉向“協作決策”，即根據患者的醫療適應性、生活方式需求、家庭環境、健康素養和支持系統來評估治療方案。另一個顯著的變化是綜合腎臟護理計畫的作用日益增強，這些計畫整合了教育、透析前計畫、血管通路準備、營養管理、藥物支持和數位後續觀察等服務。居家透析治療依賴透析液、濾芯、管路、過濾器、消毒劑和緊急援助的可靠供應，因此供應穩定性和耗材物流變得日益重要。監管機構和臨床指南持續強調易用性、病人安全、感染預防和培訓熟練度，鼓勵製造商和醫療機構設計能夠降低安裝複雜性和減少治療錯誤的解決方案。這些變化正使居家透析系統更具擴充性、互聯性，並與現代慢性病照護路徑相契合。

人工智慧對居家透析系統的累積影響

人工智慧 (AI) 正透過個人化治療、遠端監測、工作流程自動化、預測性警報和臨床決策支援等方式，開始影響家庭透析系統。 AI 驅動的分析功能與連網醫療設備和電子健康記錄相結合，可以幫助識別治療偏差、治療缺失、超過濾模式、體液平衡問題、通路相關併發症以及患者報告症狀的趨勢。在居家腹膜透析中，演算法驅動的工具可以幫助監測滯留模式、引流量、警報和治療依從性。在家庭血液透析中，它們可以幫助評估設備性能、壓力趨勢、電導率異常和治療一致性。對於臨床醫生而言，AI 可以透過優先處理需要介入的患者並在併發症惡化前及早聯繫他們，從而減輕數據過載的負擔。對於患者而言，智慧介面可以幫助進行設定指導、故障排除、提醒和教育鞏固，但這些工具需要在安全性、透明度、易用性和公平性方面檢驗。人工智慧的累積影響取決於高品質、可互通的數據、安全的連接、隱私合規性、減少偏見以及清晰的臨床管治。人工智慧應作為腎臟病專家的補充，而非替代，尤其是在居家透析決策涉及諸多複雜因素的情況下，例如殘餘腎功能、合併症、血管通路狀況、感染風險、看護者的可用性以及患者意願。如果應用得當，人工智慧可以透過改善護理的連續性、實現預防性監測、減少不必要的中斷以及支持更個人化的腎臟替代療法來提升居家透析的效果。

全球家庭透析系統的關鍵區域洞察

在亞太地區，龐大的人口基數、糖尿病和高血壓盛行率的上升、慢性腎臟病篩檢的擴大以及都市區透析基礎設施日益成長的壓力等因素，正強勁推動著家庭透析系統的發展。該地區成熟的醫療體系強調技術驅動的居家照護，而新興經濟體則致力於改善家庭透析服務的可及性、成本效益、培訓和供應物流。北美地區在家庭透析的普及方面仍然高度發達，這得益於完善的腎臟病網路、鼓勵家庭治療的報銷機制、患者教育計劃以及遠端監測和遠距遠端醫療的日益普及。美國和加拿大也越來越重視以價值為導向的腎臟照護、治療教育和早期過渡規劃。在拉丁美洲，隨著公共和私人醫療體系努力解決透析服務可近性差異、地理障礙和成本限制等問題，情況正逐漸改善。在那些因距離和醫療機構容量限制而難以頻繁前往醫療機構接受治療的地區，家庭腹膜透析發揮著尤為重要的作用。在歐洲，其優勢在於健全的臨床管治、國家腎臟登記系統、品質標準以及患者在治療方案製定中廣泛的選擇權。與一些資源匱乏的地區相比，西歐和北歐的醫療保健系統通常更有利於實施數位化驅動的居家治療。在中東，人們對居家透析系統的興趣日益濃厚，尤其是在糖尿病腎病變問題嚴重的地區，因為各國政府都在加強對專科醫療、慢性病管理和醫療現代化的投入。非洲面臨最嚴峻的醫療服務可近性挑戰，包括腎臟科醫師短缺、經濟拮据、基礎設施不完善以及複雜的供應鏈。然而，如果能夠提供可靠的耗材、進行感染控制教育並建立完善的病患追蹤系統，居家透析可以在某些都市區和轉診醫療機構發揮重要的策略作用。

影響居家透析普及的關鍵群體特定見解

在東南亞國協，居家透析的環境正呈現多樣化。發達的都市區正在引入自動化腹膜透析和互聯護理，而資源匱乏的地區則優先考慮基本醫療服務、醫護人員培訓和成本效益。海灣合作理事會（GCC）國家的特點是慢性病盛行率高、醫療保健投資巨大以及現代化的專科醫療服務體系。在物流和護理教育完善的地區，居家透析系統能夠有效減少病患對醫院的依賴，並提高病患的便利性。歐盟透過醫療設備法規、病人安全標準、跨境臨床合作以及支持慢性病綜合護理的政策，為居家透析提供了有利的框架，但其具體實施情況因報銷機制、人員配備能力和國家腎臟護理實踐而異。金磚國家整體上面臨沉重的腎臟疾病負擔，且基礎設施各不相同。中國、印度和巴西面臨著規模和可及性方面的挑戰，而俄羅斯和南非則因地區條件、支付結構和專科醫護人員分佈的不同而呈現出不同的需求。由於完善的報銷機制、醫療設備法規、數位醫療基礎設施、腎臟病學專業知識和病患支援項目，七國集團（G7）國家在家庭透析系統方面普遍準備充分；然而，人員短缺和醫療保健差距仍然是重大障礙。北約成員國與北美和歐洲的先進醫療保健系統高度重合，在這些地區，對於聯網家庭透析設備和遠端臨床監測而言，具有韌性的醫療供應鏈、網路安全預期和護理連續性計劃正變得日益重要。

各國對居家透析系統的了解

美國是受政策影響最大的家庭透析國家之一，腎臟護理改革、報銷獎勵、遠端醫療的引入以及針對治療方法的患者教育，都支持了家庭血液透析和腹膜透析的更廣泛應用。加拿大受益於公共醫療保健系統、省級腎臟計畫和強力的臨床監管，但區域因素使得遠距支持和物資供應特別重要。在墨西哥和巴西，儘管慢性腎臟病的需求不斷成長，但醫療保健服務取得方面的差距也日益凸顯，因此在培訓、報銷和物資供應能夠得到可靠協調的地區，家庭透析顯得尤為重要。在英國，結構化的腎臟護理路徑和國家醫療服務體系（NHS）的規劃為家庭腎臟護理提供了支持。同時，德國、法國、義大利和西班牙將成熟的腎臟護理服務與各種報銷方案和區域護理模式結合，這些因素影響著居家透析的普及速度。俄羅斯幅員遼闊，分散式腎臟護理模式發揮了重要作用，但基礎設施和區域資源的差異影響其實施。在中國，糖尿病和高血壓盛行率的不斷上升擴大了腎臟護理的需求，而數位醫療和國產醫療設備的研發正在為未來家庭透析的普及提供支持。在印度，腎臟護理方面存在著巨大的未滿足需求，家庭腹膜透析可以改善合格的患者獲得治療的機會，但經濟負擔、公眾意識、感染預防培訓和醫療物資供應的可靠性仍然是至關重要的。日本擁有高度發展的醫療保健體系和老齡化社會，建立了嚴格的品質標準，並且越來越重視居家慢性病照護。澳洲地區大力支持遠距透析模式，包括在農村和原住民社區提供符合當地文化背景的居家治療。韓國憑藉其先進的醫療基礎設施、數位連接和強大的慢性病管理能力，正在為互聯家庭透析系統的持續發展奠定基礎。

為家庭透析行業的領導者提供的實用建議

行業領導者應優先考慮以使用者為中心的設計、簡化的設置、多語言培訓、遠端監控互通性以及強大的患者安全功能，以增強患者、看護者和臨床醫生的信心。設備開發商應投資於緊湊型平台、自動消毒、直覺的警報、減少人工操作、可靠的連接以及「網路安全設計」。醫療服務提供者應加強透析前治療教育，規範家庭評估，改善護理師主導的培訓，並建立針對警報、通路問題、供應中斷和感染問題的快速反應系統。保險公司和醫療保健系統應將報銷與治療結果、培訓品質、遠端醫療支援、耗材物流以及減輕看護者負擔掛鉤。製造商和服務合作夥伴應提高濾芯、透析液、管路、過濾器和備件供應鏈的韌性，尤其是在最後一公里配送困難的地區。此外，相關人員應透過真實世界研究來擴大證據產生範圍，評估與生活品質、住院率、治療持續率、依從性、病患體驗和健康公平性相關的結果，而不僅依賴使用指標。人工智慧和連網型設備的策略應包括透明的檢驗、臨床醫生監督、資料隱私合規性以及與現有腎臟資訊系統的整合。為提高醫療服務的公平性，領導者應為老年人、農村居民、文盲用戶和缺乏照顧支持的患者設計項目，同時確保居家透析仍然是基於臨床適用性和患者意願的選擇。

家用透析系統分析的調查方法

本執行摘要基於二手研究途徑，參考了與家庭透析系統相關的、檢驗的臨床、監管和公共衛生資訊來源。該調查方法考慮了腎臟病學指南、腎臟出版刊物、公共衛生機構、醫療設備法規結構、同行評審文獻、報銷政策文件、醫療基礎設施評估以及家庭血液透析和腹膜透析的臨床最佳實踐等證據。分析評估了需求促進因素，例如慢性腎臟病盛行率、糖尿病和高血壓負擔、人口老化、透析途徑面臨的挑戰、遠端醫療的普及以及以患者為中心的護理重點。此外，還檢視了供應側因素，例如設備易用性、耗材物流、遠端監測能力、安全標準、培訓要求、網路安全預期和上市後監管。透過比較醫療系統成熟度、報銷結構、腎臟專家人才儲備、地理准入障礙、慢性病趨勢、數位醫療準備和法規環境，整合了區域、群體和國家層面的具體見解。本研究有意排除市場規模估算和預測、市場規模計算、市場佔有率和預測。相反，它側重於描述家用透析系統準備、臨床相關性和策略方向的定性、數據支援的指標。

結論：家用透析系統的未來

隨著醫療體系致力於建構更安全、更柔軟性、以病人為中心的治療模式，居家透析系統正從小眾治療方式轉變為現代腎臟照護的核心要素。在健保報銷系統、腎臟科醫生培訓、遠端監測、耗材物流和病患教育協調一致的地區，居家透析的發展勢頭最為強勁。居家血液透析和腹膜透析可以減少合格的患者對醫療機構的依賴，同時增強患者的自主性並保障治療的連續性。然而，成功實施居家透析需要嚴格的臨床篩選、全面的訓練、可靠的耗材供應、感染防治以及快速的技術支援。人工智慧和互聯平台有望促進監測的改進和個人化護理的實現，前提是這些技術能夠以透明、檢驗、隱私保護和臨床醫生管治為前提進行部署。目前，區域差異仍然顯著。先進的醫療體系優先考慮數位整合和以結果為導向的護理，而新興市場則優先考慮可負擔性、可近性和可靠的基礎設施。將安全醫療設備創新、循證護理模式、公平獲取策略和可互通的數位生態系統相結合的行業領導者，將最有能力推動家庭腎臟替代療法的下一階段發展。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 家用透析系統市場：依模式分類

  • 居家血液透析
    • 傳統血液透析
    • 夜間血液透析
    • 短期門診血液透析
  • 腹膜透析
    • 自動化腹膜透析
    • 持續性移動腹膜透析

第8章 家用透析系統市場：依產品類型分類

  • 透析機
  • 透析液供應系統
    • 濃縮液酸
    • 碳酸氫鹽溶液
  • 透析液
  • 血液迴路裝置
  • 透析機

第9章 家用透析系統市場：依系統類型分類

  • 可攜式系統
  • 穿戴式系統
  • 靜止系統
  • 緊湊系統

第10章 家用透析系統市場：依治療類型分類

  • 急性居家透析
  • 慢性居家透析

第11章 家用透析系統市場：依病患類型分類

  • 成人
  • 兒童
  • 老年人

第12章 家用透析系統市場：依最終用戶分類

  • 居家醫療
  • 門診部
  • 長期照護機構
  • 透析中心
  • 醫院

第13章：家用透析系統市場：依分銷管道分類

  • 線上
  • 零售

第14章 家用透析系統市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第15章 家用透析系統市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 家用透析系統市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第18章：公司簡介

  • Allmed Medical Care Holdings Limited
  • Asahi Kasei Corporation
  • AWAK Technologies
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Cook Medical Inc.
  • DaVita Inc.
  • Dialife SA
  • Diaverum AB
  • Fresenius Medical Care AG & Co. KGaA
  • Huaren Pharmaceutical Co. Ltd.
  • JMS Co. Ltd.
  • Kawasumi Laboratories Inc.
  • Medionics International Inc.
  • Medtronic plc
  • Newsol Technologies Inc.
  • Nikkiso Co. Ltd.
  • Nipro Corporation
  • Outset Medical Inc.
  • Poly Medicure Limited
  • Quanta Dialysis Technologies
  • Teleflex Incorporated
  • Terumo Corporation
  • Toray Medical Co. Ltd.
  • Utah Medical Products Inc.
Product Code: MRR-0D217D5ADC94

The Home Dialysis Systems Market is projected to grow by USD 56.28 billion at a CAGR of 10.91% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 27.25 billion
Estimated Year [2026] USD 30.20 billion
Forecast Year [2032] USD 56.28 billion
CAGR (%) 10.91%

Home Dialysis Systems Executive Summary

Home dialysis systems are becoming a critical pillar of renal replacement therapy as health systems respond to rising chronic kidney disease burden, increasing end-stage kidney disease prevalence, aging populations, and the need for patient-centered care delivery. Home hemodialysis and peritoneal dialysis enable eligible patients to conduct treatment outside traditional in-center settings, supported by compact dialysis machines, automated peritoneal dialysis cyclers, remote monitoring tools, disposable consumables, water treatment components, vascular access management, and telehealth-enabled clinical oversight. The shift toward home-based kidney care is supported by clinical evidence and clinical practice guidelines showing that appropriately selected and trained patients can achieve safe, effective therapy at home while gaining flexibility, reduced travel burden, and improved treatment autonomy. For providers and payers, home dialysis systems align with priorities around care decentralization, dialysis capacity management, infection risk mitigation, and long-term management of chronic disease. The sector is shaped by regulatory requirements for medical device safety, dialysis water quality, biocompatible materials, human factors engineering, cybersecurity, training protocols, reimbursement design, and caregiver support. As kidney care evolves from clinic-centric treatment toward connected, personalized, and outcomes-oriented models, home dialysis systems are increasingly positioned at the intersection of medical device innovation, digital health, nephrology services, and value-based care.

Transformative Shifts in the Home Dialysis Landscape

The home dialysis systems landscape is being transformed by the convergence of miniaturized device design, remote patient monitoring, tele-nephrology, simplified user interfaces, and stronger policy focus on home-based care. Historically, dialysis delivery depended heavily on in-center infrastructure, fixed treatment schedules, and frequent patient transportation. Today, patient-friendly cyclers, connected hemodialysis platforms, automated alarms, cloud-enabled treatment data, and improved training models are supporting broader use among suitable patients. Clinical practice is also shifting toward shared decision-making, with nephrologists, nurses, patients, and caregivers assessing modality choice based on medical suitability, lifestyle needs, home environment, health literacy, and support systems. Another important transformation is the growing role of integrated kidney care programs that combine education, predialysis planning, access preparation, nutrition management, medication support, and digital follow-up. Supply resilience and consumable logistics have become more important as home therapy depends on reliable delivery of dialysate, cartridges, tubing, filters, disinfectants, and emergency support. Regulatory agencies and clinical guidelines continue to emphasize device usability, patient safety, infection prevention, and training competency, encouraging manufacturers and care networks to design solutions that reduce setup complexity and treatment errors. These shifts are making home dialysis systems more scalable, connected, and aligned with modern chronic care pathways.

Cumulative Impact of Artificial Intelligence on Home Dialysis Systems

Artificial intelligence is beginning to influence home dialysis systems through treatment personalization, remote surveillance, workflow automation, predictive alerts, and clinical decision support. AI-enabled analytics can help identify treatment deviations, missed sessions, unusual ultrafiltration patterns, fluid balance concerns, access-related complications, and patient-reported symptom trends when integrated with connected devices and electronic health records. In home peritoneal dialysis, algorithmic tools can support monitoring of dwell patterns, drain volumes, alarms, and therapy adherence, while in home hemodialysis they can help assess machine performance, pressure trends, conductivity events, and treatment consistency. For clinicians, AI may reduce data overload by prioritizing patients requiring intervention and enabling earlier outreach before complications escalate. For patients, intelligent interfaces can support guided setup, troubleshooting, reminders, and education reinforcement, though these tools must be validated for safety, transparency, usability, and equity. The cumulative impact of AI will depend on high-quality interoperable data, secure connectivity, privacy compliance, bias mitigation, and clear clinical governance. AI should augment rather than replace nephrology expertise, particularly because home dialysis decisions involve complex factors such as residual kidney function, comorbidities, vascular access status, infection risk, caregiver availability, and patient preference. When responsibly deployed, AI can strengthen home dialysis by improving continuity of care, enabling proactive monitoring, reducing preventable interruptions, and supporting more individualized kidney replacement therapy.

Key Regional Insights Across Global Home Dialysis Systems

Asia-Pacific is experiencing strong structural drivers for home dialysis systems due to large populations, rising diabetes and hypertension prevalence, expanding chronic kidney disease screening, and increasing pressure on urban dialysis infrastructure. Countries with mature healthcare systems in the region emphasize technology-enabled home care, while emerging economies are focused on improving access, affordability, training, and supply logistics. North America remains a highly developed environment for home dialysis adoption, supported by established nephrology networks, reimbursement mechanisms that encourage home modalities, patient education initiatives, and growing use of remote monitoring and telehealth. The United States and Canada also place increasing emphasis on value-based kidney care, modality education, and earlier transition planning. Latin America is advancing gradually as public and private systems address uneven dialysis access, geographic barriers, and cost constraints; home peritoneal dialysis has particular relevance where travel distances and center capacity limit frequent in-center treatment. Europe benefits from strong clinical governance, national kidney registries, quality standards, and broad acceptance of patient choice in modality planning, with Western and Northern European systems generally better positioned for digitally supported home therapy than some resource-constrained areas. The Middle East is seeing growing interest in home dialysis systems as governments invest in specialty care, chronic disease management, and healthcare modernization, particularly where diabetes-related kidney disease is a major concern. Africa faces the greatest access challenges, including limited nephrology workforce, affordability constraints, infrastructure gaps, and supply chain complexity; however, home dialysis can be strategically relevant in select urban and referral settings when supported by reliable consumables, infection control education, and patient follow-up systems.

Key Group Insights Shaping Home Dialysis Adoption

ASEAN countries present a diverse home dialysis environment, with advanced urban centers increasingly adopting automated peritoneal dialysis and connected care while lower-resource settings prioritize essential access, clinician training, and affordability. The GCC is shaped by high chronic disease prevalence, substantial healthcare investment, and modernization of specialty care pathways, making home dialysis systems relevant for reducing hospital dependence and supporting patient convenience where strong logistics and nursing education are available. The European Union provides a favorable framework for home dialysis through medical device regulation, patient safety standards, cross-country clinical collaboration, and policies supporting integrated chronic care, although adoption varies by reimbursement design, workforce capacity, and national kidney care practices. BRICS countries collectively represent large kidney disease burdens and highly varied infrastructure; China, India, and Brazil face scale and access challenges, while Russia and South Africa show differing needs related to geography, payer structures, and specialty workforce distribution. G7 countries generally demonstrate higher readiness for home dialysis systems due to established reimbursement pathways, device regulation, digital health infrastructure, nephrology expertise, and patient support programs, though workforce shortages and health equity gaps remain persistent barriers. NATO member states overlap significantly with advanced healthcare systems in North America and Europe, where resilient medical supply chains, cybersecurity expectations, and continuity-of-care planning are increasingly relevant to connected home dialysis devices and remote clinical monitoring.

Key Country Insights for Home Dialysis Systems

The United States is one of the most policy-influenced home dialysis environments, with kidney care reforms, reimbursement incentives, telehealth adoption, and patient modality education supporting broader use of home hemodialysis and peritoneal dialysis. Canada benefits from publicly funded healthcare structures, provincial renal programs, and strong clinical oversight, though geography makes remote support and supply delivery especially important. Mexico and Brazil face growing chronic kidney disease needs alongside access disparities, making home dialysis relevant where training, reimbursement, and consumable distribution can be reliably coordinated. The United Kingdom supports home-based renal therapy through structured kidney care pathways and national health service planning, while Germany, France, Italy, and Spain combine mature nephrology services with varying reimbursement and regional care models that influence the pace of home dialysis adoption. Russia's large geography creates a role for decentralized kidney care, but infrastructure and regional resource variation affect implementation. China is expanding kidney care capacity amid rising diabetes and hypertension, with digital health and domestic medical device development supporting future home dialysis integration. India has substantial unmet renal care needs, and home peritoneal dialysis can improve access for suitable patients, although affordability, awareness, infection prevention training, and supply reliability remain essential. Japan has a highly developed healthcare system and aging population, with strong quality standards and growing relevance for home-based chronic care. Australia's geography strongly supports remote dialysis models, including home therapy for rural and Indigenous communities when culturally appropriate support is available. South Korea combines advanced medical infrastructure, digital connectivity, and high chronic disease management capacity, positioning it for continued development of connected home dialysis systems.

Actionable Recommendations for Home Dialysis Industry Leaders

Industry leaders should prioritize user-centered design, simplified setup, multilingual training, remote monitoring interoperability, and robust patient safety features to increase confidence among patients, caregivers, and clinicians. Device developers should invest in compact platforms, automated disinfection, intuitive alarms, reduced manual handling, reliable connectivity, and cybersecurity-by-design. Care providers should strengthen modality education before dialysis initiation, standardize home assessments, improve nurse-led training, and build rapid-response support for alarms, access issues, supply disruptions, and infection concerns. Payers and health systems should align reimbursement with outcomes, training quality, telehealth support, consumable logistics, and caregiver burden reduction. Manufacturers and service partners should improve supply chain resilience for cartridges, dialysate, tubing, filters, and spare parts, particularly in regions with difficult last-mile delivery. Stakeholders should also expand evidence generation through real-world studies that evaluate quality of life, hospitalization, technique survival, adherence, patient experience, and health equity outcomes without relying solely on utilization metrics. AI and connected device strategies should include transparent validation, clinician oversight, data privacy compliance, and integration with existing renal information systems. To improve equitable access, leaders should design programs for older adults, rural populations, low-literacy users, and patients with limited caregiver support while ensuring that home dialysis remains a choice based on clinical suitability and patient preference.

Research Methodology for Home Dialysis Systems Analysis

This executive summary is developed using a secondary research approach grounded in verified clinical, regulatory, and public health sources relevant to home dialysis systems. The methodology considers evidence from nephrology guidelines, renal registry publications, public health agencies, medical device regulatory frameworks, peer-reviewed literature, reimbursement policy documents, healthcare infrastructure assessments, and clinical best practices for home hemodialysis and peritoneal dialysis. The analysis evaluates demand drivers such as chronic kidney disease prevalence, diabetes and hypertension burden, aging demographics, dialysis access challenges, telehealth adoption, and patient-centered care priorities. It also reviews supply-side factors including device usability, consumables logistics, remote monitoring capabilities, safety standards, training requirements, cybersecurity expectations, and post-market surveillance. Regional, group, and country insights are synthesized by comparing healthcare system maturity, reimbursement structures, nephrology workforce capacity, geographic access barriers, chronic disease patterns, digital health readiness, and regulatory environments. The research deliberately excludes market estimation, market sizing, market share, and forecasting, focusing instead on qualitative and data-backed indicators that explain adoption readiness, clinical relevance, and strategic direction in home dialysis systems.

Conclusion: The Future of Home Dialysis Systems

Home dialysis systems are moving from a niche modality toward a central component of modern kidney care as healthcare systems pursue safer, more flexible, and more patient-centered treatment models. The strongest momentum is visible where reimbursement, nephrology training, remote monitoring, supply logistics, and patient education are aligned. Home hemodialysis and peritoneal dialysis can reduce dependency on in-center treatment for eligible patients while improving autonomy and supporting continuity of care, but successful implementation requires rigorous clinical selection, comprehensive training, reliable consumable delivery, infection prevention, and responsive technical support. Artificial intelligence and connected platforms are expected to enhance monitoring and personalization, provided they are implemented with transparency, validation, privacy protection, and clinician governance. Regional differences remain significant: advanced healthcare systems are focused on digital integration and outcomes-based care, while emerging markets prioritize affordability, access, and infrastructure reliability. Industry leaders that combine safe device innovation, evidence-based care models, equitable access strategies, and interoperable digital ecosystems will be best positioned to support the next phase of home-based renal replacement therapy.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Home Dialysis Systems Market, by Modality

  • 7.1. Introduction
  • 7.2. Home Hemodialysis
    • 7.2.1. Conventional Hemodialysis
    • 7.2.2. Nocturnal Hemodialysis
    • 7.2.3. Short Daily Hemodialysis
  • 7.3. Peritoneal Dialysis
    • 7.3.1. Automated Peritoneal Dialysis
    • 7.3.2. Continuous Ambulatory Peritoneal Dialysis

8. Home Dialysis Systems Market, by Product Type

  • 8.1. Introduction
  • 8.2. Dialysis Machines
  • 8.3. Dialysate Delivery Systems
    • 8.3.1. Acid Concentrates
    • 8.3.2. Bicarbonate Solutions
  • 8.4. Dialysate Solutions
  • 8.5. Blood Tubing Sets
  • 8.6. Dialyzers

9. Home Dialysis Systems Market, by System Type

  • 9.1. Introduction
  • 9.2. Portable Systems
  • 9.3. Wearable Systems
  • 9.4. Stationary Systems
  • 9.5. Compact Systems

10. Home Dialysis Systems Market, by Therapy Type

  • 10.1. Introduction
  • 10.2. Acute Home Dialysis
  • 10.3. Chronic Home Dialysis

11. Home Dialysis Systems Market, by Patient Type

  • 11.1. Introduction
  • 11.2. Adult
  • 11.3. Pediatric
  • 11.4. Geriatric

12. Home Dialysis Systems Market, by End User

  • 12.1. Introduction
  • 12.2. Home Care Settings
  • 12.3. Ambulatory Care Settings
  • 12.4. Long Term Care Facilities
  • 12.5. Dialysis Centers
  • 12.6. Hospitals

13. Home Dialysis Systems Market, by Distribution Channel

  • 13.1. Introduction
  • 13.2. Online
  • 13.3. Retail

14. Home Dialysis Systems Market, by Region

  • 14.1. Asia-Pacific
  • 14.2. North America
  • 14.3. Latin America
  • 14.4. Europe
  • 14.5. Middle East
  • 14.6. Africa

15. Home Dialysis Systems Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Home Dialysis Systems Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2025
  • 17.2. FPNV Positioning Matrix, 2025
  • 17.3. Market Concentration Analysis, 2025
    • 17.3.1. Concentration Ratio (CR)
    • 17.3.2. Herfindahl Hirschman Index (HHI)
  • 17.4. Recent Developments & Impact Analysis, 2025
  • 17.5. Product Portfolio Analysis, 2025
  • 17.6. Benchmarking Analysis, 2025

18. Company Profiles

  • 18.1. Allmed Medical Care Holdings Limited
  • 18.2. Asahi Kasei Corporation
  • 18.3. AWAK Technologies
  • 18.4. B. Braun Melsungen AG
  • 18.5. Baxter International Inc.
  • 18.6. Becton, Dickinson and Company
  • 18.7. Cook Medical Inc.
  • 18.8. DaVita Inc.
  • 18.9. Dialife SA
  • 18.10. Diaverum AB
  • 18.11. Fresenius Medical Care AG & Co. KGaA
  • 18.12. Huaren Pharmaceutical Co. Ltd.
  • 18.13. JMS Co. Ltd.
  • 18.14. Kawasumi Laboratories Inc.
  • 18.15. Medionics International Inc.
  • 18.16. Medtronic plc
  • 18.17. Newsol Technologies Inc.
  • 18.18. Nikkiso Co. Ltd.
  • 18.19. Nipro Corporation
  • 18.20. Outset Medical Inc.
  • 18.21. Poly Medicure Limited
  • 18.22. Quanta Dialysis Technologies
  • 18.23. Teleflex Incorporated
  • 18.24. Terumo Corporation
  • 18.25. Toray Medical Co. Ltd.
  • 18.26. Utah Medical Products Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL HOME DIALYSIS SYSTEMS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL HOME DIALYSIS SYSTEMS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL HOME DIALYSIS SYSTEMS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL HOME DIALYSIS SYSTEMS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY THERAPY TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY THERAPY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL HOME DIALYSIS SYSTEMS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 27. GLOBAL HOME DIALYSIS SYSTEMS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL HOME DIALYSIS SYSTEMS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HOME HEMODIALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HOME HEMODIALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL HOME HEMODIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CONVENTIONAL HEMODIALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CONVENTIONAL HEMODIALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CONVENTIONAL HEMODIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL NOCTURNAL HEMODIALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL NOCTURNAL HEMODIALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NOCTURNAL HEMODIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SHORT DAILY HEMODIALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SHORT DAILY HEMODIALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SHORT DAILY HEMODIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL AUTOMATED PERITONEAL DIALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL AUTOMATED PERITONEAL DIALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL AUTOMATED PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CONTINUOUS AMBULATORY PERITONEAL DIALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CONTINUOUS AMBULATORY PERITONEAL DIALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CONTINUOUS AMBULATORY PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL DIALYSIS MACHINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL DIALYSIS MACHINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL DIALYSIS MACHINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DIALYSATE DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DIALYSATE DELIVERY SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DIALYSATE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ACID CONCENTRATES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ACID CONCENTRATES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ACID CONCENTRATES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BICARBONATE SOLUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BICARBONATE SOLUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BICARBONATE SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL DIALYSATE SOLUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL DIALYSATE SOLUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL DIALYSATE SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BLOOD TUBING SETS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BLOOD TUBING SETS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BLOOD TUBING SETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL DIALYZERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL DIALYZERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DIALYZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PORTABLE SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PORTABLE SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PORTABLE SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL WEARABLE SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL WEARABLE SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL WEARABLE SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL STATIONARY SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL STATIONARY SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL STATIONARY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL COMPACT SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL COMPACT SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL COMPACT SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ACUTE HOME DIALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ACUTE HOME DIALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ACUTE HOME DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CHRONIC HOME DIALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CHRONIC HOME DIALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CHRONIC HOME DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL GERIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL GERIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL GERIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL AMBULATORY CARE SETTINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL AMBULATORY CARE SETTINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL AMBULATORY CARE SETTINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL LONG TERM CARE FACILITIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL LONG TERM CARE FACILITIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL LONG TERM CARE FACILITIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL DIALYSIS CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL DIALYSIS CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL DIALYSIS CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL RETAIL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL RETAIL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL RETAIL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC HOME DIALYSIS SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC HOME DIALYSIS SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC HOME DIALYSIS SYSTEMS MARKET SIZE, BY DIALYSATE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC HOME DIALYSIS SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC HOME DIALYSIS SYSTEMS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC HOME DIALYSIS SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY DIALYSATE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY DIALYSATE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE HOME DIALYSIS SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE HOME DIALYSIS SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE HOME DIALYSIS SYSTEMS MARKET SIZE, BY DIALYSATE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE HOME DIALYSIS SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE HOME DIALYSIS SYSTEMS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE HOME DIALYSIS SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST HOME DIALYSIS SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST HOME DIALYSIS SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST HOME DIALYSIS SYSTEMS MARKET SIZE, BY DIALYSATE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST HOME DIALYSIS SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST HOME DIALYSIS SYSTEMS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST HOME DIALYSIS SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY DIALYSATE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN HOME DIALYSIS SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN HOME DIALYSIS SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN HOME DIALYSIS SYSTEMS MARKET SIZE, BY DIALYSATE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN HOME DIALYSIS SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN HOME DIALYSIS SYSTEMS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN HOME DIALYSIS SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 179. GCC HOME DIALYSIS SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. GCC HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 181. GCC HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 182. GCC HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 183. GCC HOME DIALYSIS SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. GCC HOME DIALYSIS SYSTEMS MARKET SIZE, BY DIALYSATE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 185. GCC HOME DIALYSIS SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. GCC HOME DIALYSIS SYSTEMS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. GCC HOME DIALYSIS SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. GCC HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. GCC HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION HOME DIALYSIS SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION HOME DIALYSIS SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION HOME DIALYSIS SYSTEMS MARKET SIZE, BY DIALYSATE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION HOME DIALYSIS SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION HOME DIALYSIS SYSTEMS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION HOME DIALYSIS SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS HOME DIALYSIS SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS HOME DIALYSIS SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS HOME DIALYSIS SYSTEMS MARKET SIZE, BY DIALYSATE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS HOME DIALYSIS SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS HOME DIALYSIS SYSTEMS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS HOME DIALYSIS SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 212. G7 HOME DIALYSIS SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 213. G7 HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 214. G7 HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 215. G7 HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 216. G7 HOME DIALYSIS SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. G7 HOME DIALYSIS SYSTEMS MARKET SIZE, BY DIALYSATE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 218. G7 HOME DIALYSIS SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. G7 HOME DIALYSIS SYSTEMS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. G7 HOME DIALYSIS SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. G7 HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 222. G7 HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 223. NATO HOME DIALYSIS SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 224. NATO HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 225. NATO HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 226. NATO HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 227. NATO HOME DIALYSIS SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. NATO HOME DIALYSIS SYSTEMS MARKET SIZE, BY DIALYSATE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 229. NATO HOME DIALYSIS SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. NATO HOME DIALYSIS SYSTEMS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. NATO HOME DIALYSIS SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. NATO HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 233. NATO HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 234. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES HOME DIALYSIS SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES HOME DIALYSIS SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES HOME DIALYSIS SYSTEMS MARKET SIZE, BY DIALYSATE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES HOME DIALYSIS SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES HOME DIALYSIS SYSTEMS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES HOME DIALYSIS SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 246. CANADA HOME DIALYSIS SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 247. CANADA HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 248. CANADA HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 249. CANADA HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 250. CANADA HOME DIALYSIS SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. CANADA HOME DIALYSIS SYSTEMS MARKET SIZE, BY DIALYSATE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 252. CANADA HOME DIALYSIS SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. CANADA HOME DIALYSIS SYSTEMS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. CANADA HOME DIALYSIS SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. CANADA HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 256. CANADA HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 257. MEXICO HOME DIALYSIS SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 258. MEXICO HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 259. MEXICO HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 260. MEXICO HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 261. MEXICO HOME DIALYSIS SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 262. MEXICO HOME DIALYSIS SYSTEMS MARKET SIZE, BY DIALYSATE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 263. MEXICO HOME DIALYSIS SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. MEXICO HOME DIALYSIS SYSTEMS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. MEXICO HOME DIALYSIS SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. MEXICO HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 267. MEXICO HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 268. BRAZIL HOME DIALYSIS SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 269. BRAZIL HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 270. BRAZIL HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 271. BRAZIL HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 272. BRAZIL HOME DIALYSIS SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 273. BRAZIL HOME DIALYSIS SYSTEMS MARKET SIZE, BY DIALYSATE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 274. BRAZIL HOME DIALYSIS SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. BRAZIL HOME DIALYSIS SYSTEMS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. BRAZIL HOME DIALYSIS SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 277. BRAZIL HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 278. BRAZIL HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 279. UNITED KINGDOM HOME DIALYSIS SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED KINGDOM HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED KINGDOM HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED KINGDOM HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED KINGDOM HOME DIALYSIS SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 284. UNITED KINGDOM HOME DIALYSIS SYSTEMS MARKET SIZE, BY DIALYSATE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 285. UNITED KINGDOM HOME DIALYSIS SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED KINGDOM HOME DIALYSIS SYSTEMS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 287. UNITED KINGDOM HOME DIALYSIS SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 288. UNITED KINGDOM HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED KINGDOM HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 290. GERMANY HOME DIALYSIS SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 291. GERMANY HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 292. GERMANY HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 293. GERMANY HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 294. GERMANY HOME DIALYSIS SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 295. GERMANY HOME DIALYSIS SYSTEMS MARKET SIZE, BY DIALYSATE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 296. GERMANY HOME DIALYSIS SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 297. GERMANY HOME DIALYSIS SYSTEMS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 298. GERMANY HOME DIALYSIS SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 299. GERMANY HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 300. GERMANY HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 301. FRANCE HOME DIALYSIS SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 302. FRANCE HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 303. FRANCE HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 304. FRANCE HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 305. FRANCE HOME DIALYSIS SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 306. FRANCE HOME DIALYSIS SYSTEMS MARKET SIZE, BY DIALYSATE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 307. FRANCE HOME DIALYSIS SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 308. FRANCE HOME DIALYSIS SYSTEMS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 309. FRANCE HOME DIALYSIS SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 310. FRANCE HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 311. FRANCE HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 312. RUSSIA HOME DIALYSIS SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 313. RUSSIA HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 314. RUSSIA HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 315. RUSSIA HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 316. RUSSIA HOME DIALYSIS SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 317. RUSSIA HOME DIALYSIS SYSTEMS MARKET SIZE, BY DIALYSATE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 318. RUSSIA HOME DIALYSIS SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 319. RUSSIA HOME DIALYSIS SYSTEMS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 320. RUSSIA HOME DIALYSIS SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 321. RUSSIA HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 322. RUSSIA HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 323. ITALY HOME DIALYSIS SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 324. ITALY HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 325. ITALY HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 326. ITALY HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 327. ITALY HOME DIALYSIS SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 328. ITALY HOME DIALYSIS SYSTEMS MARKET SIZE, BY DIALYSATE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 329. ITALY HOME DIALYSIS SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 330. ITALY HOME DIALYSIS SYSTEMS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 331. ITALY HOME DIALYSIS SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 332. ITALY HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 333. ITALY HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 334. SPAIN HOME DIALYSIS SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 335. SPAIN HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 336. SPAIN HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 337. SPAIN HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 338. SPAIN HOME DIALYSIS SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 339. SPAIN HOME DIALYSIS SYSTEMS MARKET SIZE, BY DIALYSATE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 340. SPAIN HOME DIALYSIS SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 341. SPAIN HOME DIALYSIS SYSTEMS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 342. SPAIN HOME DIALYSIS SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 343. SPAIN HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 344. SPAIN HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 345. CHINA HOME DIALYSIS SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 346. CHINA HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 347. CHINA HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 348. CHINA HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 349. CHINA HOME DIALYSIS SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 350. CHINA HOME DIALYSIS SYSTEMS MARKET SIZE, BY DIALYSATE DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 351. CHINA HOME DIALYSIS SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 352. CHINA HOME DIALYSIS SYSTEMS MARKET SIZE, BY THERAPY TYPE,